Summary

KEY FINDINGS
The Europe computed tomography (CT) scanners market is set to rise with a CAGR of 5.19% across the forecasting period of 2023 to 2032. Key drivers reinforcing the region’s market growth include the use of artificial intelligence (AI) in CT scanners and the rise in R&D activities aimed at medical imaging as well as advancements in CT technology.
MARKET INSIGHTS
The Europe computed tomography (CT) scanners market growth analysis includes the study of the United Kingdom, Spain, Belgium, Poland, Germany, France, Italy, and Rest of Europe. Computed tomography (CT) scanners hold significant importance within France’s thriving healthcare industry. Recognized for its advanced healthcare system and cutting-edge medical technology, the nation exhibits a strong demand for CT scanners across diverse healthcare facilities. In this regard, Eurostat data reveals that among the EU Member States, France recorded the highest healthcare expenditure relative to GDP in 2020, underlining its commitment to healthcare investment.
In France, over recent years, there has been a steady rise in the proportion of the population aged 75 or older. In 2022, this age group already represented 9% of the population, with projections indicating a further increase to 13% by 2032 and 16% by 2052. Additionally, the elderly population faces a higher incidence of chronic illnesses and multiple pathologies, with a staggering 91% affected by at least one chronic condition or undergoing continuous treatment. Consequently, the expansion and adoption of CT scanners in France are driven by a combination of technological advancements and the growing prevalence of chronic diseases. As a result, these factors are anticipated to propel the market growth in Europe over the forecast period.
COMPETITIVE INSIGHTS
Some of the eminent companies operating in the market include Siemens Healthineers AG, Planmeca Group, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASES
3.1.2. INCREASING AWARENESS ABOUT EARLY DIAGNOSIS
3.1.3. ACCELERATED GROWTH OF HOSPITAL & HEALTHCARE INFRASTRUCTURE IN EMERGING COUNTRIES
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF EQUIPMENT INSTALLATION AND MAINTENANCE
3.2.2. LACK OF ADEQUATE REIMBURSEMENT AND STRINGENT REGULATORY FRAMEWORK
3.2.3. DEARTH OF WELL-TRAINED AND SKILLED HEALTHCARE PROFESSIONALS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET CONCENTRATION ANALYSIS
5. MARKET BY TYPE
5.1. HIGH-END SLICE
5.2. MID-END SLICE
5.3. LOW-END SLICE
5.4. CONE BEAM
6. MARKET BY APPLICATION
6.1. ONCOLOGY
6.2. NEUROLOGY
6.3. CARDIOVASCULAR
6.4. MUSCULOSKELETAL
6.5. OTHER APPLICATIONS
7. MARKET BY END-USER
7.1. HOSPITALS & CLINICS
7.2. DIAGNOSTIC CENTERS
7.3. OTHER END-USERS
8. GEOGRAPHICAL ANALYSIS
8.1. EUROPE
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. EUROPE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET DRIVERS
8.1.3. EUROPE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET CHALLENGES
8.1.4. KEY PLAYERS IN EUROPE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED KINGDOM
8.1.5.1.1. UNITED KINGDOM COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
8.1.5.2. GERMANY
8.1.5.2.1. GERMANY COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
8.1.5.3. FRANCE
8.1.5.3.1. FRANCE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
8.1.5.4. ITALY
8.1.5.4.1. ITALY COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
8.1.5.5. SPAIN
8.1.5.5.1. SPAIN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
8.1.5.6. BELGIUM
8.1.5.6.1. BELGIUM COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
8.1.5.7. POLAND
8.1.5.7.1. POLAND COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
8.1.5.8. REST OF EUROPE
8.1.5.8.1. REST OF EUROPE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ANALOGIC CORPORATION
9.2.2. CANON MEDICAL SYSTEMS CORP
9.2.3. CARESTREAM HEALTH
9.2.4. FUJIFILM HOLDINGS CORPORATION
9.2.5. GE HEALTHCARE
9.2.6. KONING CORPORATION
9.2.7. KONINKLIJKE PHILIPS NV
9.2.8. NEUSOFT MEDICAL SYSTEMS
9.2.9. PLANMECA GROUP
9.2.10. SAMSUNG ELECTRONICS
9.2.11. SHENZHEN ANKE HIGH-TECH CO LTD
9.2.12. SHIMADZU CORPORATION
9.2.13. SIEMENS HEALTHINEERS AG
9.2.14. STRYKER CORPORATION